The DHR-flow cytometric assay is the laboratory gold standard for screening CGD, with genetic testing available to confirm CGD when mutations are found in CYBB, CYBA, NCF1, NCF2, NCF4, and CYBC1 (13). The gene discussed is CYBC1; the disease is chronic granulomatous disease.